Of those mentioned above, the synthetic STAT3 inhibitor napabucasin seems to be the most promising compound, due to its high efficiency and very low toxicity, mainly due to a higher affinity for cancer than normal cells [83]. This evidence concerns the gene STAT3 and cancer.